Thousands of people in Britain are dealing with a puzzling and severe dermatological condition that has stumped doctors. Sufferers describe their skin as becoming intensely inflamed with cracking and peeling, frequently across their whole body, yet many doctors find it difficult to diagnose and treat the condition. The condition, known as topical steroid withdrawal (TSW) or red skin syndrome, has created considerable interest on online platforms, with clips featuring patients’ experiences receiving more than a billion views on TikTok alone. Despite affecting a growing number of people, TSW is so little understood that some doctors and dermatologists doubt whether it exists at all. Now, for the first time, researchers in the UK are undertaking a significant research project to investigate what is behind these mysterious symptoms and reasons why some people develop the condition whilst others do not.
The Mysterious Ailment Sweeping Across the UK
Bethany Gamble’s case exemplifies the profound effects of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had controlled her eczema effectively with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became severely inflamed and reddened, cracking and oozing whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so acute that she was confined to her bed, requiring round-the-clock care from her mother. Most concerning, Bethany experienced repeated dismissal by healthcare providers who ascribed her symptoms to standard eczema and continued prescribing the very treatments she believed were causing her suffering.
The medical establishment remains divided on how to manage TSW, with deep divisions about its very nature. Some experts regard it as a debilitating allergic reaction to the topical steroids that serve as the primary treatment for eczema across the NHS. Others maintain it constitutes a acute flare-up of pre-existing skin conditions rather than a distinct syndrome, whilst a small number are sceptical of its existence altogether. This lack of professional consensus has put patients like Bethany caught in a state of diagnostic limbo, having difficulty accessing proper treatment. The failure to reach consensus has prompted Professor Sara Brown at the Edinburgh University to create the first significant UK research initiative investigating TSW, funded by the National Eczema Society.
- Symptoms comprise severe inflammation, cracking skin and intense itching across the body
- Patients document “elephant skin” hardening and excessive flaking of dead skin cells
- Healthcare practitioners frequently overlook TSW as standard eczema or decline to recognise it
- The condition may prove so debilitating that sufferers lack the capacity to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Controllable Eczema to Disabling Symptoms
For many sufferers, topical steroid withdrawal constitutes a severe decline from a previously stable dermatological condition. What starts with intermittent itching in areas of skin fold can rapidly escalate into a widespread inflammatory reaction that leaves patients incapable of functioning. The change typically happens abruptly, without warning, converting a manageable chronic condition into an severe medical emergency. People describe their skin turning intensely hot, inflamed and red, with severe cracking and weeping that requires constant attention. The physical toll is compounded by exhaustion, as the relentless itching disrupts sleep and recovery, establishing a destructive cycle of decline.
The rate at which TSW unfolds catches many sufferers by surprise. Those who have experienced eczema for years, sometimes decades, are unprepared for the severity of symptoms that develop when their condition suddenly worsens. Routine activities become overwhelming difficulties: showering becomes excruciating, dressing demands help, and keeping clean demands enormous effort. Some patients report feeling as though their skin is being attacked from within, with inflammation extending over their body in patterns that differ markedly to their previous eczema flare-ups. This dramatic transformation often drives sufferers to obtain emergency care, only to encounter disbelief from healthcare professionals.
The Fight for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the dismissive medical responses that frequently accompanies it. Patients experiencing severe, unexplained symptoms are consistently informed they merely suffer from eczema worsening, despite their assertion that this is essentially distinct from anything they’ve experienced before. Doctors often respond by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers feeling abandoned by the healthcare system, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their concerns dismissed as anxiety or psychological rather than genuine physiological symptoms.
The lack of medical consensus has created a significant divide between what patients report and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists struggle to identify TSW or offer appropriate support. Some clinicians remain entirely unconvinced the condition exists, treating all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty results in delayed diagnosis, inappropriate treatment and significant emotional suffering for patients already suffering physically. The growing visibility of TSW on social media has drawn attention to this diagnostic void, prompting researchers to examine the experiences reported by vast numbers of individuals, even as the healthcare profession continues to disagree on the appropriate response.
- Symptoms can emerge abruptly in people with previously stable eczema managed by steroid creams
- Patients frequently encounter scepticism from medical practitioners who ascribe worsening to typical eczema exacerbations
- Medical professionals remain divided on whether TSW is a genuine condition or severe eczema exacerbation
- Lack of established diagnostic standards means numerous patients struggle to access appropriate treatment and assistance
- Social media has magnified patient voices, with TSW hashtags accumulating more than one billion views globally
Racial Disparities in Assessment and Clinical Management
The diagnostic complexities surrounding topical steroid withdrawal become increasingly evident amongst individuals with darker skin, where symptoms can be significantly harder to identify visually. Erythema and inflammatory responses, the characteristic indicators of TSW in lighter-skinned individuals, present distinctly across different ethnic groups, yet many assessment protocols remain centred on how the condition appears in white patients. This difference means that Black, Asian and other people of colour experiencing TSW frequently encounter even greater delays in identification and acceptance. Clinical practitioners trained primarily on manifestations in lighter-skinned individuals may overlook or misinterpret the typical indicators, leading to continued misidentification and unsuitable therapeutic suggestions that can worsen symptoms.
Research into TSW has traditionally overlooked the lived experiences with deeper skin tones, perpetuating a cycle where their condition goes insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been largely shaped by voices with lighter skin, risking distortion of medical understanding and public awareness. As Professor Sara Brown’s pioneering British research advances, guaranteeing inclusive participation amongst participants will be essential to creating genuinely comprehensive diagnostic criteria and treatment approaches. Without deliberate efforts to centre the experiences of all ethnic groups, treatment inequalities in TSW recognition and management threaten to increase, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Emerging Research and Care Options Coming to Light
Initial Major UK Study In Progress
Professor Sara Brown’s groundbreaking research at the University of Edinburgh constitutes a watershed moment for TSW sufferers seeking validation and comprehension. Supported by the National Eczema Society, the study has brought together numerous participants across the UK to investigate the biological mechanisms underlying topical steroid withdrawal. By examining symptoms, saliva samples and skin biopsies, researchers seek to identify why particular individuals experience TSW whilst others on identical steroid regimens do not. This detailed analysis marks a important transition from dismissal to serious investigation.
The research team working alongside Dr Alice Burleigh from advocacy group for patients Scratch That, brings both clinical expertise and personal experience to the investigation. Their joint methodology accepts that patients themselves hold essential understanding into their health situations. Professor Brown has identified patterns in TSW that cannot be accounted for by traditional understanding of eczema, including marked “elephant skin” thickening, severe shedding and sharply demarcated areas of inflammation. The research findings could substantially alter how healthcare practitioners handle diagnosis and care of this debilitating condition.
Available Treatments and Their Limitations
At present, treatment options for TSW continue to be limited and often unsatisfactory. Many healthcare professionals keep prescribing topical steroids notwithstanding evidence implying they might intensify symptoms in those predisposed. Some patients describe short-term improvement from moisturisers, antihistamines and systemic drugs, though responses vary considerably. Dermatologists are split on best treatment approaches, with some recommending full steroid withdrawal whilst others advocate phased withdrawal. This lack of consensus leaves patients navigating their therapeutic pathways mostly in isolation, relying heavily on peer support networks and web-based forums for direction.
Psychological assistance with specialist dermatological care offer potential benefits, yet access remains patchy across the NHS. Some patients have investigated complementary methods including dietary modifications, environmental controls and holistic therapies, though scientific evidence validating such approaches is limited. The lack of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to support the skin’s protective barrier and minimise water loss
- Antihistamines to alleviate itching and associated sleep disturbance in flare episodes
- Oral corticosteroids or immunosuppressants for serious presentations under specialist supervision
- Mental health support to manage emotional distress and worry related to chronic skin conditions
Testimonies of Aspiration and Perseverance
Despite the uncertainty surrounding TSW and the often dismissive perspectives from medical practitioners, patients are finding strength in shared community and collective experience. Digital support communities have become lifelines for those struggling with the disorder, offering validation and practical advice when traditional medicine has let them down. Many sufferers describe the moment they discovered the TSW hashtag as pivotal—finally finding others with identical symptoms and recognising they were not alone in their suffering. This collective voice has been powerful enough to prompt the initial serious research initiatives, demonstrating that patient-led campaigns can advance medical understanding even when established institutions stay unconvinced.
Bethany Gamble and people in similar situations are determined to raise awareness and advocate for due recognition of TSW within the medical establishment. Their willingness to share deeply personal accounts of their difficulties on online platforms has encouraged open dialogue around a disorder that numerous physicians still decline to recognise. These patients are not waiting passively for solutions; they are engaging in research studies, tracking their signs meticulously, and requiring that their testimonies be taken seriously. Their determination in the face of chronic suffering and invalidating medical treatment provides encouragement that answers may finally be within attainment, and that those to come will be given the acknowledgement and treatment they urgently require.
- Community-driven research projects are filling gaps left by traditional medical institutions and advancing knowledge of TSW
- Online communities provide psychological assistance, practical coping strategies, and mutual recognition for isolated sufferers worldwide
- Advocacy efforts are incrementally changing clinical attitudes, encouraging dermatologists to examine rather than overlook patient concerns
